Date published: 2026-3-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

CSA Inhibitors

CSA inhibitors, also known as cyclosporine A inhibitors, belong to a distinct chemical class that plays a pivotal role in modulating immune responses. At the core of these inhibitors lies cyclosporine A, a cyclic polypeptide found in the fungus Tolypocladium inflatum. Cyclosporine A itself is a potent immunosuppressive agent, widely recognized for its ability to selectively target and inhibit the activity of calcineurin, a key enzyme in T-cell activation. The chemical structure of CSA inhibitors is characterized by a cyclic undecapeptide backbone, consisting of amino acids with a unique arrangement. Specifically, it comprises a combination of non-proteinogenic amino acids, such as MeBmt (N-methylbutylthreonine), Nva (norvaline), and D-Ala (D-alanine), which contribute to the distinctive properties of CSA inhibitors. Within the cellular milieu, CSA inhibitors exert their effects by forming complexes with cyclophilin, a peptidyl-prolyl cis-trans isomerase, leading to the formation of a potent immunosuppressive complex. This complex subsequently binds to calcineurin, inhibiting its phosphatase activity and impeding the dephosphorylation of nuclear factor of activated T cells (NFAT). As a result, the translocation of NFAT to the nucleus is hindered, impeding the transcription of genes involved in the immune response. The intricate interplay between cyclosporine A, cyclophilin, and calcineurin forms the basis of CSA inhibitors' immunosuppressive mechanism, making them valuable tools in various biological contexts where the modulation of immune responses is crucial.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Purvalanol B

212844-54-7sc-361300
sc-361300A
10 mg
50 mg
$199.00
$846.00
(1)

Purvalanol A competitively inhibits ATP binding to CDK2, halting its kinase activity.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

Roscovitine selectively binds to the ATP pocket of CDK2, reducing its phosphorylation capabilities.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

Flavopiridol inhibits CDK2 by competitive inhibition of ATP and blocks cell cycle progression.

Olomoucine

101622-51-9sc-3509
sc-3509A
5 mg
25 mg
$72.00
$274.00
12
(1)

Olomoucine mimics the structure of ATP and competes for its binding site on CDK2.

Indirubin

479-41-4sc-201531
sc-201531A
5 mg
25 mg
$114.00
$525.00
4
(1)

Indirubin intercalates in the ATP-binding site, preventing CDK2 activity.

4′-Methylpropiophenone

5337-93-9sc-252233
100 g
$66.00
(0)

Butyrolactone binds to CDK2 and alters its conformation, thus inhibiting its function.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

Palbociclib selectively inhibits CDK2 by blocking ATP-binding, disrupting cell division.

Ribociclib

1211441-98-3sc-507367
10 mg
$450.00
(0)

Ribociclib binds to and inhibits CDK2, leading to G1 phase arrest in the cell cycle.

Abemaciclib

1231929-97-7sc-507342
10 mg
$110.00
(0)

Abemaciclib binds to CDK2, preventing ATP binding and phosphorylation of target substrates.

Dinaciclib

779353-01-4sc-364483
sc-364483A
5 mg
25 mg
$247.00
$888.00
1
(0)

Dinaciclib robustly binds to CDK2 and blocks its enzymatic phosphorylation activity.